CLDN18.2 May Define Lung Adenocarcinoma Phenotype - Summary - MDSpire

CLDN18.2 May Define Lung Adenocarcinoma Phenotype

Frequent CLDN18.2 expression was associated with gastric-type differentiation and reduced spread through air spaces in pulmonary invasive mucinous adenocarcinoma.

  • By

  • Andrea Surnit

  • July 22, 2026

  • 3 min

Share

Original Source(s)

CLDN18.2 May Define Lung Adenocarcinoma Phenotype

  • by Andrea Surnit

  • July 22, 2026

Related Content

Can Proteomics Refine Lung Screening?

Proteomic biomarkers improve short-term lung cancer risk assessment.

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.

Hypoxic Exosomes Drive CCL26 in HNSCC

Hypoxia-induced vesicles reshape endothelial signaling and may promote tumor-associated phenotypes in head and neck squamous cell carcinoma